These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 8547842)
1. Calpain activity of hypertrophic hearts from hypertensive rats. Cicilini MA; Resende MM; Bissoli NS; Vasquez EC; Cabral AM Braz J Med Biol Res; 1995 Jun; 28(6):621-5. PubMed ID: 8547842 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of protein and peptide hydrolases in DOCA-salt hypertensive rat treated with chlorthalidone. Santos-Costa JL; Bissoli NS; Cabral AM; Cicilini MA Braz J Med Biol Res; 1996 Nov; 29(11):1431-5. PubMed ID: 9196540 [TBL] [Abstract][Full Text] [Related]
3. Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury? Harwood SM; Allen DA; Chesser AM; New DI; Raftery MJ; Yaqoob MM Kidney Int; 2003 Mar; 63(3):866-77. PubMed ID: 12631067 [TBL] [Abstract][Full Text] [Related]
5. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. Ebrahim Z; Yellon DM; Baxter GF Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163 [TBL] [Abstract][Full Text] [Related]
6. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats. O'Brien D; Chunduri P; Iyer A; Brown L Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879 [TBL] [Abstract][Full Text] [Related]
7. Induction of hypertension and cardiac hypertrophy in guinea pig by DOCA salt. Tiritilli A; Ruff F Methods Find Exp Clin Pharmacol; 1994; 16(6):391-6. PubMed ID: 7837830 [TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458 [TBL] [Abstract][Full Text] [Related]
9. Protein synthesis in the hypertrophied heart of spontaneously hypertensive rats and a comparison of the effects of an ACE-inhibitor and a calcium channel antagonist. Patel VB; Siddiq T; Richardson PJ; Preedy VR Cell Biochem Funct; 1995 Jun; 13(2):111-24. PubMed ID: 7538913 [TBL] [Abstract][Full Text] [Related]
10. High salt intake accelerated cardiac remodeling in spontaneously hypertensive rats: time window of left ventricular functional transition and its relation to salt-loading doses. Gao F; Han ZQ; Zhou X; Shi R; Dong Y; Jiang TM; Li YM Clin Exp Hypertens; 2011; 33(7):492-9. PubMed ID: 21529316 [TBL] [Abstract][Full Text] [Related]
11. [Role of valsartan on myocardial Calpain I, calcineurin and Ca/calmodulin-dependent protein kinase IIδ expression of renovascular hypertensive rats]. Lu JY; Zhu JH; Qin XT; Yu XH; Sheng HZ Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Jun; 40(6):511-5. PubMed ID: 22943648 [TBL] [Abstract][Full Text] [Related]
12. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Chamorro V; Wangensteen R; Sainz J; Duarte J; O'Valle F; Osuna A; Vargas F Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506 [TBL] [Abstract][Full Text] [Related]
13. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats. Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats. Iyer A; Woodruff TM; Wu MC; Stylianou C; Reid RC; Fairlie DP; Taylor SM; Brown L J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735 [TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats. Pietranera L; Saravia F; Gonzalez Deniselle MC; Roig P; Lima A; De Nicola AF J Neuroendocrinol; 2006 Jun; 18(6):466-74. PubMed ID: 16684136 [TBL] [Abstract][Full Text] [Related]
16. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats. Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289 [TBL] [Abstract][Full Text] [Related]
17. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation. Prahalathan P; Kumar S; Raja B Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933 [TBL] [Abstract][Full Text] [Related]
18. Renal AT1 receptor: computerized quantification in spontaneously hypertensive rats and DOCA-salt rats. Asano N; Ogura T; Mimura Y; Otsuka F; Kishida M; Hashimoto M; Yamauchi T; Makino H Res Commun Mol Pathol Pharmacol; 1998 May; 100(2):171-80. PubMed ID: 9667071 [TBL] [Abstract][Full Text] [Related]
19. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815 [TBL] [Abstract][Full Text] [Related]
20. Wall stress induced arrhythmia is enhanced by low potassium and early left ventricular hypertrophy in the working rat heart. Evans SJ; Levi AJ; Jones JV Cardiovasc Res; 1995 Apr; 29(4):555-62. PubMed ID: 7796450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]